| Positive Rankings |
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Cara Therapeutics Inc. is ranked 112. |
Low vPut/Call
Cara Therapeutics Inc. has a low Put/Call ratio of 0.14 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Cara Therapeutics Inc. is ranked 223. |
10 Day Gain
Cara Therapeutics Inc. rank is 1179 |
Low Put/Call
Cara Therapeutics Inc. has a low Put/Call ratio of 0.52 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Cara Therapeutics Inc. is ranked 1261. |
| Negative Rankings |
Missed Whisper
According to EarningsWhispers.com, Cara Therapeutics Inc. missed the Earnings Whisper ® number when it last reported earnings. Statistics show that companies that have missed the Earnings Whisper ® number underperform the market in the short-term. |
90 Day Loss
Cara Therapeutics Inc. rank is 521 |
Down EPS Surprise
Cara Therapeutics Inc. missed the consensus earnings estimate when it last reported quarterly earnings. |
